Trial Profile
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Evaluation of the Efficacy and Safety of DEX-IN Following Painful Outpatient Procedures
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2023
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Fentanyl
- Indications Pain
- Focus Therapeutic Use
- Sponsors Recro Pharma
- 11 Nov 2019 Status changed from recruiting to completed.
- 22 Nov 2017 New trial record